Brief: CMS Grants TDAPA Reimbursement For Vafseo
10/10/2024 13:12
Oct 10 (Reuters) - Akebia Therapeutics Inc AKBA.O :
* AKEBIA THERAPEUTICS INC: CMS GRANTS TDAPA REIMBURSEMENT
FOR
VAFSEO (VADADUSTAT) BEGINNING JAN 1, 2025
* AKEBIA THERAPEUTICS INC: TDAPA PROGRAM PROVIDES TWO YEARS
OF
REIMBURSEMENT FOR VAFSEO IN ADDITION TO ESRD BUNDLED RATE TO
DIALYSIS ORGANIZATIONS
Source text for Eikon: ID:nPn3S5h80a
Further company coverage: AKBA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule